Literature DB >> 25433639

Pervasive axonal transport deficits in multiple sclerosis models.

Catherine Diamante Sorbara1, Naomi Elizabeth Wagner2, Anne Ladwig2, Ivana Nikić2, Doron Merkler3, Tatjana Kleele4, Petar Marinković4, Ronald Naumann5, Leanne Godinho4, Florence Martine Bareyre6, Derron Bishop7, Thomas Misgeld8, Martin Kerschensteiner9.   

Abstract

Impaired axonal transport can contribute to axon degeneration and has been described in many neurodegenerative diseases. Multiple sclerosis (MS) is a common neuroinflammatory disease, which is characterized by progressive axon degeneration-whether, when, and how axonal transport is affected in this condition is unknown. Here we used in vivo two-photon imaging to directly assay transport of organelles and the stability of microtubule tracks in individual spinal axons in mouse models of MS. We found widespread transport deficits, which preceded structural alterations of axons, cargos, or microtubules and could be reversed by acute anti-inflammatory interventions or redox scavenging. Our study shows that acute neuroinflammation induces a pervasive state of reversible axonal dysfunction, which coincides with acute disease symptoms. Moreover, perpetuated transport dysfunction, as we found in a model of progressive MS, led to reduced distal organelle supply and could thus contribute to axonal dystrophy in advanced stages of the disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25433639     DOI: 10.1016/j.neuron.2014.11.006

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  61 in total

1.  Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach.

Authors:  Sebastian Rühling; Franziska Kramer; Selina Schmutz; Sandra Amor; Zhan Jiangshan; Christoph Schmitz; Markus Kipp; Tanja Hochstrasser
Journal:  Mol Neurobiol       Date:  2018-09-21       Impact factor: 5.590

2.  Calibrated imaging reveals altered grey matter metabolism related to white matter microstructure and symptom severity in multiple sclerosis.

Authors:  Nicholas A Hubbard; Monroe P Turner; Minhui Ouyang; Lyndahl Himes; Binu P Thomas; Joanna L Hutchison; Shawheen Faghihahmadabadi; Scott L Davis; Jeremy F Strain; Jeffrey Spence; Daniel C Krawczyk; Hao Huang; Hanzhang Lu; John Hart; Teresa C Frohman; Elliot M Frohman; Darin T Okuda; Bart Rypma
Journal:  Hum Brain Mapp       Date:  2017-08-16       Impact factor: 5.038

Review 3.  Neurodegeneration in Progressive Multiple Sclerosis.

Authors:  Graham Campbell; Don Mahad
Journal:  Cold Spring Harb Perspect Med       Date:  2018-10-01       Impact factor: 6.915

4.  Progressive Decrease of Mitochondrial Motility during Maturation of Cortical Axons In Vitro and In Vivo.

Authors:  Tommy L Lewis; Gergely F Turi; Seok-Kyu Kwon; Attila Losonczy; Franck Polleux
Journal:  Curr Biol       Date:  2016-09-15       Impact factor: 10.834

Review 5.  Nogo-A Antibodies for Progressive Multiple Sclerosis.

Authors:  Benjamin V Ineichen; Patricia S Plattner; Nicolas Good; Roland Martin; Michael Linnebank; Martin E Schwab
Journal:  CNS Drugs       Date:  2017-03       Impact factor: 5.749

Review 6.  Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular Architecture.

Authors:  Thomas Misgeld; Thomas L Schwarz
Journal:  Neuron       Date:  2017-11-01       Impact factor: 17.173

Review 7.  A review of possible therapies for multiple sclerosis.

Authors:  Hui Li; Gaojian Lian; Guang Wang; Qianmei Yin; Zehong Su
Journal:  Mol Cell Biochem       Date:  2021-04-22       Impact factor: 3.396

8.  Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.

Authors:  Jae Young Lee; Min Joung Kim; Speros Thomas; Viola Oorschot; Georg Ramm; Pei Mun Aui; Yuichi Sekine; Devy Deliyanti; Jennifer Wilkinson-Berka; Be'eri Niego; Alan R Harvey; Paschalis Theotokis; Catriona McLean; Stephen M Strittmatter; Steven Petratos
Journal:  J Neurosci       Date:  2019-05-06       Impact factor: 6.167

9.  Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation.

Authors:  Michael A Wheeler; Merja Jaronen; Ruxandra Covacu; Stephanie E J Zandee; Giulia Scalisi; Veit Rothhammer; Emily C Tjon; Chun-Cheih Chao; Jessica E Kenison; Manon Blain; Vijayaraghava T S Rao; Patrick Hewson; Andreia Barroso; Cristina Gutiérrez-Vázquez; Alexandre Prat; Jack P Antel; Russ Hauser; Francisco J Quintana
Journal:  Cell       Date:  2019-01-17       Impact factor: 41.582

Review 10.  Axonal transport and neurological disease.

Authors:  James N Sleigh; Alexander M Rossor; Alexander D Fellows; Andrew P Tosolini; Giampietro Schiavo
Journal:  Nat Rev Neurol       Date:  2019-09-26       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.